CHRU de Brest
Brest, France
Location status: Recruiting
Location contact
Sandrine JOUSSE-JOULIN
CONTACT
NCT Number: NCT04320680
Diagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest ( France)
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Brest, France
Location status: Recruiting
Sandrine JOUSSE-JOULIN
CONTACT
all patients coming to the LUPUS multidisciplinary consultation in brest ( France) will have a clinical examination, a biological and immunogical blood samples, cutaneous biopsies or renal biospies if necessary, an ultrasonographic articular and salivary glandular examination if needed. In case of articular involvement, some Xrays ( hands and feet) will be done at the inclusion and during the follow up each year during 5 years .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
description of a lupus patient cohort
Time frame: five years
epidemiologic lupus study in collecting data ( description of the population, biologic and immunologic data collection, data of articular damges with xrays datas) about Diagnosis and follow up of a cohort lupus in a multidisciplibnary consultation in brest hospital ( France).
Contact information is provided by the study sponsor or research team.
alain saraux, MD, PHD
CONTACT
sandrine jousse joulin, MD
CONTACT
University Hospital, Brest
Other
Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest
Acronym: CO LUPUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001372
Autoimmune Diseases, Connective Tissue Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00756769
Autoimmune Diseases, Connective Tissue Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT07260877
Autoimmune Diseases, CLE
Beverly Hills, California, United States
View Trial DetailsNCT07598396
Autoimmune Diseases, Connective Tissue Diseases
Salvador, Estado de Bahia, Brazil
View Trial Details